Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Medidata and inVentiv Health announced a multi-year partnership to bring patient-centric technology and clinical trial expertise to the biopharmaceutical industry.
read more
Thursday, September 14, 2017
Invicro announced the acquisition of UK-based Imanova.
read more
Friday, February 26, 2016
inviCRO, LLC, and Molecular NeuroImaging, LLC, both providers of imaging service solutions and analysis for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the ...
read more
Monday, November 06, 2017
InVitria has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany.
read more
InVivo Therapeutics has entered into a common stock purchase agreement with Lincoln Park Capital Fund under which the company has the right to sell up to $15 million in shares of common stock.
read more
Invivoscribe announces the launch of a fully integrated drug development engine.
read more
Invivotek, LLC, a Genesis Biotechnology Group® (GBG) company and in vivo pharmacology contract research organization (CRO), announced the completion of the Genesis Solar Farm adjacent to its newly expanded preclinical research facility in Hamilton, ...
read more
Tuesday, February 20, 2018
Ionis Pharmaceuticals has licensed IONIS-AZ5-2.5Rx (AZD2373) to AstraZeneca.
read more
Thursday, November 16, 2017
Ionis Pharmaceuticals has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech for which Ionis earned $5 million.
read more
Monday, December 18, 2017
Ionis announced its license agreement with Roche to develop and commercialize IONIS-HTTRx has received clearance under the Hart-Scott-Rodino Antitrust Improvements Act.
read more
Tuesday, October 13, 2020
IonSense has announced the first shipments of their next-generation JumpShot Technology enabled DART source.
read more
IonSense and WHALE Biolabs announced a strategic alliance to provide analytical services for chemists utilizing HTE in their laboratories.
read more
Wednesday, February 02, 2022
IonsGate Preclinical Services Inc InSilicoTrials have announced a partnership to leverage innovative technology like Modeling and Simulation.
read more
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, announced that F-star Therapeutics dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.
read more
Wednesday, March 10, 2021
IONTAS and FairJourney Biologics have announced that they have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms.
read more